Startups
AOBiome Therapeutics, Inc.
Edit

AOBiome Therapeutics, Inc.

http://www.aobiome.com/
Last activity: 21.05.2025
Active
Categories: DeliveryDevelopmentHealthTechHumanLifeLocalManufacturingProductResearchSkin
AOBiome Therapeutics, Inc. life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. AOBiome has a pipeline of multiple, clinical-stage therapeutic candidates
Likes
4.38K
Followers
1.45K
Followers
1.45K
Mentions
11

Overview

Location
United States, Massachusetts, Cambridge
Employees
11-50
Total raised
$30M
Founded date
2013

Investors 2

DateNameWebsite
Sign up to seeSign up to seeSign up to see
MBC BioLabsmbcbiolabs.com

Funding Rounds 1

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see

Mentions in press and media 11

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Oct 9, 2024USPTO Grants AOBiome Therapeutics Composition of Matter Patent for its Clinical Candidate B244B244 has demonstrated clinical efficacy on therapeutic indications including: Atopic Dermatitis (Eczema) and Pruritus (Itch), and Acne Vulgaris (Acne) CAMBRIDGE, MA, UNITED STATES, October 9, 2024 /EINPresswire.com/ -- USPTO Grants AOBiome ...
Oct 22, 2019Azitra brings in Series A to advance microbiome skin therapiesAzitra has four topical therapies in the pipeline to treat Netherton syndrome, cancer treatment-associated rashes, eczema and ichthyosis vulgaris. Netherton is a chronic, orphan disease caused by a LEKTI protein deficiency. LEKTI regulates ...
Oct 26, 2017Bracket acquisition underscores the push to make clinical trials more flexible for patientsAdam Butler, Bracket strategic development and corporate marketing officer, said in an email that mProve has been a BYOD device pioneer and has a track record of working with pharma and regulators to make BYOD work in clinical trials. Also ...
Jan 6, 2017Term Sheet — Friday, January 6CES, CMO, IPO, CAIO Unicorn Watch: Yesterday I interviewed Xiaomi CFO Shou Zi Chew, formerly a partner at DST Global. Xiaomi, valued at $45 billion, is at CES hoping to deliver on its promise of a broad tech ecosystem offering a variety of ...
Jan 5, 2017AOBiome Partners with iCarbonX and Secures $30 Million InvestmentLeading microbiome company AOBiome announced it has partnered with iCarbonX, China's largest health data collection and analysis platform. iCarbonX was founded in 2015 by renowned genomicist Jun Wang, whose iCarbonX ecosystem has made a $30...
Sep 11, 2014Cola-Flavored Genitals, and Other Potential Uses for Microbiome HackingOne of the irritating things about Silicon Valley start-ups is their frequent insistence that they're going to save the world, which made talking to Gilad Gome, whose latest venture involves hacking your guts, pretty refreshing. "There...
May 31, 2014Spray-on bacteria is one company’s surprising idea for curing skin conditions“My skin began to change for the better. It actually became softer and smoother, rather than dry and flaky, as though a sauna’s worth of humidity had penetrated my winter-hardened shell. And my complexion, prone to hormone-related breakouts...
Azitra brings in Series A to advance microbiome skin therapiesConnecticut-based microbiome therapy company Azitra recently announced a $14 million haul in Series A funding. The round was led by KdT Ventures and previous investor Bios Partners, along with Godfrey Capital and Connecticut Innovations. Az...
Spray-on bacteria is one company’s surprising idea for curing skin conditionsIn medicine, the microbiome is most often associated with the gut. But there are millions of bacteria, viruses and fungi that live on our skin and in our glands, too, and scientists suspect that learning more about them could lead to better...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about AOBiome Therapeutics, Inc.

When was AOBiome Therapeutics, Inc. founded?

AOBiome Therapeutics, Inc. was founded in 2013.

How much funding has AOBiome Therapeutics, Inc. raised?

AOBiome Therapeutics, Inc. has raised $30M in total across 1 funding round.

Who has invested in AOBiome Therapeutics, Inc.?

Parsers VC lists 2 investors of AOBiome Therapeutics, Inc., among them MBC BioLabs.

What has the press written about AOBiome Therapeutics, Inc.?

Parsers VC has collected 11 articles mentioning AOBiome Therapeutics, Inc., among them “USPTO Grants AOBiome Therapeutics Composition of Matter Patent for its Clinical Candidate B244” (Oct 9, 2024) and “Azitra brings in Series A to advance microbiome skin therapies” (Oct 22, 2019).

Is AOBiome Therapeutics, Inc. still active?

Yes, AOBiome Therapeutics, Inc. is active; its latest activity on Parsers VC dates from May 21, 2025.